ORYZON GENOMICS S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.03 EUR | 0.00% |
|
+3.05% | +7.52% |
| 06/05 | Oryzon Genomics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 22/04 | Oryzon Genomics, S.A. Secures Another Important Patent for its Lead CNS Asset, Vafidemstat | CI |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ORYZON GENOMICS S.A. | Other Biotechnology & Medical Research | 0.00% | +3.05% | +7.52% | -4.25% | -49.88% | 127M |  | | |
- Stock Market
- Equities
- ORY Stock
- Charts Oryzon Genomics S.A.
- Relative Strength Chart